Skip to Content
Uncategorized

Nuts to That

Severe, even life-threatening peanut allergies afflict 3 million people in the United States alone. The only protection now available is to avoid peanuts and their derivatives. While it’s easy to eschew peanut butter sandwiches, who’s to know if the chips at the office party were fried in peanut oil? Houston-based Tanox has begun human testing of a once-a-month injection to protect the peanut-averse from accidental exposure. The drug, Hu-901, is an antibody that blocks the immune reaction responsible for swelling and itching. People taking it probably won’t be able to eat nuts daily, but they should have more time to get help if they do eat those chips.

If Hu-901 is effective in preventing peanut allergies, Tanox may investigate its use against other food allergies. The company hopes a similar antibody to treat seasonal allergies and asthma will get regulatory approval by mid-2001.

Deep Dive

Uncategorized

Investing in people is key to successful transformation

People-related factors like talent attraction and retention and clear top-down communication will determine whether your transformation progresses or stalls.

Work reinvented: Tech will drive the office evolution

As organizations navigate a new world of hybrid work, tech innovation will be crucial for employee connection and collaboration.

The way forward: Merging IT and operations

Digital transformation in any industry begins with bridging the gap between two traditionally separate teams.

be a good example concept
be a good example concept

Be a good example

"It was in the newspaper, but the towers fell the next day, and what I’d done was quickly lost."

Stay connected

Illustration by Rose WongIllustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.